KBC Group
AVNS

KBC Group’s Avanos Medical AVNS Stock Holding History

KBC Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,833
Closed -$41K – 1726
2025
Q1 		$41K Hold
2,833
– – ﹤0.01% 1820
2024
Q4 		$45K Hold
2,833
– – ﹤0.01% 1821
2024
Q3 		$68K Buy
2,833
+1,095
+63% +$25K ﹤0.01% 1542
2024
Q2 		$35K Hold
1,738
– – ﹤0.01% 1776
2024
Q1 		$35K Hold
1,738
– – ﹤0.01% 1711
2023
Q4 		$39K Hold
1,738
– – ﹤0.01% 1679
2023
Q3 		$35K Sell
1,738
-1,856
-52% -$42.1K ﹤0.01% 1694
2023
Q2 		$92K Hold
3,594
– – ﹤0.01% 1210
2023
Q1 		$107K Sell
3,594
-531
-13% -$15.4K ﹤0.01% 1178
2022
Q4 		$112K Hold
4,125
– – ﹤0.01% 1162
2022
Q3 		$90K Hold
4,125
– – ﹤0.01% 1226
2022
Q2 		$113K Buy
4,125
+639
+18% +$18.4K ﹤0.01% 1178
2022
Q1 		$117K Buy
3,486
+1,948
+127% +$62.7K ﹤0.01% 1146
2021
Q4 		$53K Hold
1,538
– – ﹤0.01% 1243
2021
Q3 		$48K Buy
+1,538
New +$52.2K ﹤0.01% 1239
2016
Q2 		– Sell
-656
Closed -$19K – 1282
2016
Q1 		$19K Sell
656
-733
-53% -$19.5K ﹤0.01% 1231
2015
Q4 		$46K Sell
1,389
-599
-30% -$18.6K ﹤0.01% 1196
2015
Q3 		$57K Sell
1,988
-59,090
-97% -$2.06M ﹤0.01% 1213
2015
Q2 		$2.47M Sell
61,078
-3,900
-6% -$175K 0.03% 487
2015
Q1 		$3.2M Buy
64,978
+25,966
+67% +$1.2M 0.04% 414
2014
Q4 		$1.77M Buy
+39,012
New +$1.53M 0.02% 613

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KBC Group's AVNS Position: Q2 2025 in Review

KBC Group sold out of Avanos Medical (AVNS) in Q2 2025, closing a stake of 2,833 shares — an estimated $41K sold.

KBC Group first reported a position in AVNS in Q4 2014 and held it in 21 quarters. The position peaked at $3.2M in Q1 2015. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2025.

  • KBC Group reported no remaining Avanos Medical position as of Q2 2025 after selling out during the quarter.
  • KBC Group sold 2,833 Avanos Medical shares in Q2 2025, an estimated $41K.
  • KBC Group first reported a position in Avanos Medical in Q4 2014 and held it in 21 quarters.
  • KBC Group's Avanos Medical position peaked at $3.2M in Q1 2015.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2025.

Based on KBC Group's 13F filing for Q2 2025, filed 8 Aug 2025.